Needs



Statement of Needs

Eighty percent of diabetic patients die of heart disease. Recently published post hoc analyses of long-term trials of lipid-modifying therapy have demonstrated clinical benefit in the subgroup of patients with diabetes, but diabetic dyslipidemia and associated cardiovascular risk factors continue to be difficult to manage successfully. Several treatment options have become available in the past year that make prevention a more attainable goal in patients with diabetes or the metabolic syndrome. Because aggressive lipid-modifying therapy in patients with diabetes can reduce coronary heart disease morbiditydisease morbidity and mortality, there is a need to provide medical professionals with up-to-date information on diagnosis and treatment of dyslipidemias in these high-risk patients.

Educational Objectives

Upon completion of the activity, participants should be able to explain and discuss:

• Emerging concepts modalities for risk assessment in patients with the metabolic syndrome or diabetes

• Benefits of treatment of lipid disorders in patients with diabetes

• Identification and treatment of the metabolic syndrome.

• Benefits of combination therapy (statin, niacin, ezetimibe, and fibrates) in the treatment of diabetic dyslipidemias

• Management of multiple lipid abnormalities in patients with diabetes

.

Target Audience

Internists, Family Practice PracticPhysicianse, General PracticPractitionerse, Endocrinologistsy

Evaluation Method

Evaluation by questionnaire will address program content, presentation, and possible bias.

Accreditation/Credit Designation

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Baylor College of Medicine designates this educational activity for a maximum of 4.0XX hours in category 1 credits toward the AMA Physician’s Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the activity.

Program Schedule – Date Saturday, July 19 , 2003

7:30 AM Registration and Continental Breakfast

8:00 Diabetic dyslipidemia Dyslipidemia and Ccardiovascular Rrisk:; Eevidence from Cclinical Ttrials with Llipid Ttherapy

Christie M. Ballantyne, MD

Baylor College of Medicine, Houston, Texasx

8:45 Reducing Cardiovascular Risk in Diabetic patients - Beyond LDL-CholesterolManagement of the diabetic patient: How much benefit from lipid therapy, blood pressure and glucose control?

Charles A. Reasner-II, MD

Charles A. Reasner, II, MD

University of Texas Health Science Center

San Antonio, TexasX

9:30 Break

9:30 Break

9:45 Achievement of Gguidelines in Ddaily Ppractice: Helping Patients The Stay out of Trouble! primary care perspective

Scott E. Connard, MD

The University of Texas Southwestern Medical Center, Dallas, TexasX

10:30 Case Ppresentation and Ppanel Ddiscussion

Faculty

12:151:15 Adjournment

REGISTRATION FORM

Name

First, MI, Last, Degree

Affiliation

Address

City, State, Zip

Phone Fax

Email Specialty

Degree Year Social Security Number

-----------------------

Registration Fee

( $25.00??35? Physicians

( $35 Allied Health Professionals

Method of Payment (specify)

( Check (Make payable to Baylor College of Medicine)

( Credit Card

( Visa® ( MasterCard® ( DISCOVER®

| |

|CK CC Cash |

|Date: |

|Amount: |

Supported by an educational grant from KOS Pharmaceuticals, Inc.

Space is limited. Pre-registration is required.

If you do not receive your confirmation within 2 weeks of your registration, please contact Danièele Zoch, 713.798.3336.

-----------------------

[pic]

Presented by

Baylor College of Medicine

Department of Medicine

Section of Atherosclerosis and Lipoprotein Research

................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download